-
Featured News /
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
-
Featured News /
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
-
Featured News /Novartis transforms its Global Health & Corporate Responsibility organization.
-
Story /New head of oncology research hopes to build on recent advances, explore new therapeutic approaches and beat certain cancers for good.
-
Story /New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
-
Story /By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
-
Featured News /
From January 21-24 2020, Novartis attended the World Economic Forum Annual Meeting in Davos, Switzerland.
-
Statement /
-
Story /Experts call for significant changes to facilitate the discovery of new treatments.
-
Featured News /
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.